Cefepime Injection IP

Cefepime Injection IP

Product Details:

  • Pacakaging (Quantity Per Box) 1 Vial + 1 Ampoule Water for Injection
  • Brand Name Cefepime Injection IP
  • Dosage Form Powder for Injection
  • Salt Composition Cefepime Hydrochloride (Equivalent to Cefepime 1g)
  • Indication Severe infections caused by susceptible organisms
  • Packaging Type Glass Vial, with carton box
  • Origin of Medicine India
  • Click to view more
X

Cefepime Injection IP Price And Quantity

  • 100 Pack
  • Marketed under drug license in India
  • Known allergy to cephalosporins or beta-lactam antibiotics
  • Recommended before therapy initiation
  • J01DE01
  • WHO-GMP Certified Facility
  • White to pale yellow powder
  • Sterile Water for Injection
  • Use immediately or within 24 hours if refrigerated
  • Prescription required
  • Do not mix with solutions containing aminoglycosides
  • Not for self-medication; use under medical supervision
  • Intravenous (IV) or Intramuscular (IM)

Cefepime Injection IP Product Specifications

  • Severe infections caused by susceptible organisms
  • Prescription Only (Rx)
  • Bacterial Infections, septicemia, pneumonia, urinary tract infections, skin and skin structure infections
  • Store below 25C in a dry place, protect from light
  • India
  • Glass Vial, with carton box
  • 24 months from the date of manufacture
  • 1 g per vial
  • Adults and Pediatric Patients (as advised)
  • Cefepime Hydrochloride 1 g/vial
  • 1 Vial + 1 Ampoule Water for Injection
  • Antibiotic/Cephalosporin
  • As directed by the physician; commonly 1 g to 2 g every 12 hours IV/IM
  • Reconstitute with sterile water for injection and administer as per doctors advice
  • Cefepime Hydrochloride (Equivalent to Cefepime 1g)
  • Lyophilized Powder for Injection
  • Cefepime Injection IP
  • Powder for Injection
  • Marketed under drug license in India
  • Known allergy to cephalosporins or beta-lactam antibiotics
  • Recommended before therapy initiation
  • J01DE01
  • WHO-GMP Certified Facility
  • White to pale yellow powder
  • Sterile Water for Injection
  • Use immediately or within 24 hours if refrigerated
  • Prescription required
  • Do not mix with solutions containing aminoglycosides
  • Not for self-medication; use under medical supervision
  • Intravenous (IV) or Intramuscular (IM)

Cefepime Injection IP Trade Information

  • Cash in Advance (CID)
  • 5000 Pack Per Month
  • 10 Days
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India

Product Description



Discover an exceptional deal on the acclaimed Cefepime Injection IP-a classic, renowned antibiotic formulated for the management of severe bacterial infections. Available at a reduced price, this imposing solution is designed for intravenous (IV) or intramuscular (IM) administration after reconstitution with sterile water. Manufactured in a WHO-GMP certified facility and approved for the Indian market, this prescription-only product is supplied in a glass vial with carton packaging. Its efficacy makes it a staple in treating septicemia, pneumonia, urinary tract and skin infections. Sensitivity testing is recommended to ensure suitability. Not for self-medication-use strictly under medical supervision.

Comprehensive Clinical Usage and Material Benefits

Cefepime Injection IP is engineered for direct hospital and medical use, ideal for combating a multitude of bacterial infections from urinary tract issues to pneumonia. Each lyophilized glass vial contains top-grade Cefepime Hydrochloride, formulated for optimal patient outcomes. Its feature of rapid reconstitution with sterile water ensures timely administration, supporting both adult and pediatric therapies as recommended by healthcare professionals.


Market Availability, Certifications, and Logistics

As a trusted supplier and trader across India's major regions, Cefepime Injection IP is marketed under a valid drug license and manufactured in WHO-GMP certified facilities. Samples are available for evaluation upon request. Clients can estimate arrival times through reliable transport services, ensuring that the product is delivered safely and promptly at their preferred destination. Each unit arrives with a certification of quality, supporting safe medical practice.


FAQ's of Cefepime Injection IP:


Q: How should Cefepime Injection IP be administered?

A: Cefepime Injection IP is administered either intravenously (IV) or intramuscularly (IM) after reconstituting the lyophilized powder with sterile water for injection, as directed by a medical professional.

Q: What precautions should be taken before starting therapy with Cefepime Injection IP?

A: A sensitivity test is recommended before beginning therapy to ensure the antibiotic's suitability for the patient. This precaution helps minimize adverse reactions and ensures effective treatment.

Q: Where is Cefepime Injection IP manufactured and is it certified?

A: Cefepime Injection IP is produced in India at a WHO-GMP certified facility, ensuring adherence to the highest quality and safety standards.

Q: When should reconstituted Cefepime Injection IP be used?

A: The injection should be used immediately after reconstitution. If refrigeration is available, it may be used within 24 hours, but using it as soon as possible is advised for maximum efficacy.

Q: What are the main benefits of using Cefepime Injection IP?

A: Cefepime Injection IP offers broad-spectrum antibacterial action against a range of severe infections, such as septicemia and pneumonia. Its proven efficacy and quality assurance make it a prime choice in clinical settings.

Q: How do I store Cefepime Injection IP and its components?

A: Store the lyophilized powder below 25C in a dry place, protected from light. After reconstitution, keep the solution refrigerated if not used immediately, and discard if unused after 24 hours.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Pharmaceutical Injection' category



Back to top